Searched for
ASTRAZENECA EARNINGS
Ahead of Market: 10 things that will decide stock market action on MondayIndian stock markets experienced sharp cuts on Thursday, with Nifty and Sensex declining due to rising oil prices and a falling rupee. Sell...- UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...
- Global Markets | European markets dip as investors eye earnings, Iran conflict continues to weighEuropean shares dipped on Wednesday, as investors turned their focus to a packed day of corporate earnings, while a continuing U.S.-Iran im...
- AstraZeneca Pharma India shares rise over 2% after CDSCO clears Imfinzi for new cancer useAstraZeneca Pharma India shares saw a rise after Imfinzi got approval for expanded use. The CDSCO approved it as a first-line treatment for...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
- AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...
- AstraZeneca starts to make modest profit from Covid-19 vaccineThe Anglo-Swedish company's third-quarter results showed the vaccine contributed one cent to core earnings per share of $1.08, a rise of 14...
- AstraZeneca says on track to deliver on Covid shots as sales hit $275 mnWhen including production and distribution from partners such as the Serum Institute of India, more than 300 million doses have been suppli...
- Not perfect, but saves lives, AstraZeneca says of COVID-19 vaccineThe two-dose shot, developed with Oxford University, has been hailed as a "vaccine for the world" because it is cheaper and easier to distr...
- AstraZeneca to acquire Alexion in $39 billion dealAlexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.
- Covid-19 vaccine deliveries on ice as AstraZeneca awaits trial dataAstraZeneca said on Thursday it was holding back deliveries while it awaits the data from late-stage clinical trials in order to maximise t...
- Trending stocks: AstraZeneca Pharma shares gain over 1%A total of 1,321 shares changed hands on the counter till 11:40AM (IST).
- AstraZeneca sells ageing beta-blocker to Recordati for $300 mlnAstraZeneca, which retains rights to the beta-blocker outside Europe, will continue to manufacture and ship product to Recordati under a su...
- AstraZeneca Pharma Q4 net profit at Rs 38 croreNet sales stood at Rs 120.80 crore during the quarter, while the same were at Rs 114.14 crore during the same period in the previous fiscal.
- Connecticut AG George Jepsen to USFDA: Pull up Ranbaxy for failing to launch drug NexiumRanbaxy was scheduled to launch the generic version of drug Nexium in US under a 6-month exclusive marketing opportunity, but it failed to ...
- Astrazeneca Pharma Q3 net loss at Rs 18 croreAstrazeneca Pharma today posted a net loss of Rs 17.69 crore for its third quarter ended December 31, 2012.
- Ranbaxy Laboratories to supply low-cost version of Nexium by 2011-endAstraZeneca is awaiting approval from USFDA but we expect to start shipping the product in the second half of this year.
- AstraZeneca plans to double job cutsAstraZeneca PLC said it will more than double previously planned job cuts as it revealed Thursday that quarterly profit fell 12.5 per cent.
- IBM, AstraZeneca in $1.4 bn dealIBM Corp said on Monday it has won a $1.4 billion (euro1 billion) outsourcing contract from AstraZeneca PLC.
Load More
